Exact Mass: 452.201
Exact Mass Matches: 452.201
Found 248 metabolites which its exact mass value is equals to given mass value 452.201
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
8-Butanoylneosolaniol
8-Butanoylneosolaniol is produced by Fusarium sporotrichioides.
8-Isobutanoylneosolaniol
8-Isobutanoylneosolaniol is produced by Fusarium sporotrichioides. Production by Fusarium sporotrichioides
2-(3-(4-((1H-Indazol-5-yl)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide
9alpha-Acetoxymelnerin B
[3aR-(3aalpha,4aalpha,5alpha,7abeta,9abeta)]-5-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3a,4,4a,5,6,7,7a,9a-octahydro-5,8-dimethyl-3-methylene-azuleno[6,5-b]furan-2(3H)-one
Absinthifolide
4,8,12-Tris(acetyloxy)-10-[(acetyloxy)methyl]-2,6-dimethyl-2,6,10-dodecatrienal
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] (Z)-4-acetyloxy-2-(hydroxymethyl)but-2-enoate
(7R,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,3-dimethoxy-8-O-4-neolignan
1-<4-O-(2-hydroxy-1-hydroxymethylethyl)-3-methoxyphenyl>-2-<4-(1-propanol)-3-methoxyphenyl>-propane-1,3-diol|1-[4-O-(2-hydroxy-1-hydroxymethylethyl)-3-methoxyphenyl]-2-[4-(1-propanol)-3-methoxyphenyl]-propane-1,3-diol
1,3-Di(4-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene-2,7-diol
Tetra-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetrio
ochrindole A
A bisindole alkaloid that is phenol bearing a 3,3-dimethylallyl group at position 4, two methoxy groups at positions 3 and 6, and two indol-3-yl groups at positions 2 and 5. It is a natural product isolated from the sclerotia of Aspergillus orbraceus, with moderate activity against some insects, as well as Gram-positive bacteria.
(1R*,4R*,5R*,8S*,10R*)-1,4-Epoxy-1-ethoxy-5-hydroxy-8-methacryloxy-13-acetoxygermacra-5E,7(11)-dien-6,12-olide
2,7-((1,1-Bi(1H-indole)-3,3-diyl)bismethylene)dodecahydrocyclobutadipyrazine-3,6-dione
Fluocinolone Acetonide
C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid S - Sensory organs > S02 - Otologicals > S02B - Corticosteroids > S02BA - Corticosteroids D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8722; ORIGINAL_PRECURSOR_SCAN_NO 8717 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8755; ORIGINAL_PRECURSOR_SCAN_NO 8753 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8759; ORIGINAL_PRECURSOR_SCAN_NO 8757 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8810; ORIGINAL_PRECURSOR_SCAN_NO 8805 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8806; ORIGINAL_PRECURSOR_SCAN_NO 8804 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8815; ORIGINAL_PRECURSOR_SCAN_NO 8813 CONFIDENCE standard compound; INTERNAL_ID 2402
C23H32O9_Cyclohexaneacetic acid, 6-[4-(acetyloxy)-3-hydroxy-2-methylene-1-oxobutoxy]-4-ethenyl-2-hydroxy-3-[1-(hydroxymethyl)ethenyl]-4-methyl-alpha-methylene-, methyl ester
C23H32O9_D-Glucitol, 1,5-anhydro-1-C-[2,6-dihydroxy-3-(methoxycarbonyl)-4-[(3Z,5Z)-3,5-nonadien-1-yl]phenyl]-, (1S)
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 4-acetyloxy-3-hydroxy-2-methylidenebutanoate
methyl 2,4-dihydroxy-6-[(3Z,5Z)-nona-3,5-dienyl]-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzoate
Ala Cys Phe Ile
Ala Cys Phe Leu
Ala Cys Ile Phe
Ala Cys Leu Phe
Ala Glu His Pro
Ala Glu Pro His
Ala Phe Cys Ile
Ala Phe Cys Leu
Ala Phe Ile Cys
Ala Phe Leu Cys
Ala His Glu Pro
Ala His Pro Glu
Ala Ile Cys Phe
Ala Ile Phe Cys
Ala Leu Cys Phe
Ala Leu Phe Cys
Ala Pro Glu His
Ala Pro His Glu
Cys Ala Phe Ile
Cys Ala Phe Leu
Cys Ala Ile Phe
Cys Ala Leu Phe
Cys Phe Ala Ile
Cys Phe Ala Leu
Cys Phe Ile Ala
Cys Phe Leu Ala
Cys Ile Ala Phe
Cys Ile Phe Ala
Cys Leu Ala Phe
Cys Leu Phe Ala
Glu Ala His Pro
Glu Ala Pro His
Glu His Ala Pro
Glu His Pro Ala
Glu Pro Ala His
Glu Pro His Ala
Phe Ala Cys Ile
Phe Ala Cys Leu
Phe Ala Ile Cys
Phe Ala Leu Cys
Phe Cys Ala Ile
Phe Cys Ala Leu
Phe Cys Ile Ala
Phe Cys Leu Ala
Phe Gly Met Val
Phe Gly Val Met
Phe Ile Ala Cys
Phe Ile Cys Ala
Phe Leu Ala Cys
Phe Leu Cys Ala
Phe Met Gly Val
Phe Met Val Gly
Phe Val Gly Met
Phe Val Met Gly
Gly Phe Met Val
Gly Phe Val Met
Gly Met Phe Val
Gly Met Val Phe
Gly Val Phe Met
Gly Val Met Phe
His Ala Glu Pro
His Ala Pro Glu
His Glu Ala Pro
His Glu Pro Ala
His Pro Ala Glu
His Pro Glu Ala
Ile Ala Cys Phe
Ile Ala Phe Cys
Ile Cys Ala Phe
Ile Cys Phe Ala
Ile Phe Ala Cys
Ile Phe Cys Ala
Leu Ala Cys Phe
Leu Ala Phe Cys
Leu Cys Ala Phe
Leu Cys Phe Ala
Leu Phe Ala Cys
Leu Phe Cys Ala
Met Phe Gly Val
Met Phe Val Gly
Met Gly Phe Val
Met Gly Val Phe
Met Thr Thr Thr
Met Val Phe Gly
Met Val Gly Phe
Pro Ala Glu His
Pro Ala His Glu
Pro Glu Ala His
Pro Glu His Ala
Pro His Ala Glu
Pro His Glu Ala
Thr Met Thr Thr
Thr Thr Met Thr
Thr Thr Thr Met
Val Phe Gly Met
Val Phe Met Gly
Val Gly Phe Met
Val Gly Met Phe
Val Met Phe Gly
Val Met Gly Phe
6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, (6b,11b,16b,17a)-Androsta-1,4-diene-17-c
8-Butanoylneosolaniol
8-Isobutanoylneosolaniol
3-Hydroxy-4-(3-hydroxy-1-propen-2-yl)-2-(3-methoxy-3-oxo-1-propen-2-yl)-5-methyl-5-vinylcyclohexyl 4-acetoxy-3-hydroxy-2-methylenebutanoate
6-amino-5-[(2-cyano-4-nitrophenyl)azo]-2-[[3-(4-hydroxybutoxy)propyl]amino]-4-methyl-3-Pyridinecarbonitrile
2-amino-5-[(2-cyano-4-nitrophenyl)azo]-6-[[3-(4-hydroxybutoxy) propyl]amino]-4-methyl-3-Pyridinecarbonitrile
TERT-BUTYL6-(5-(METHOXYCARBONYL)PYRIDIN-3-YL)-4-OXOSPIRO[CHROMAN-2,4-PIPERIDINE]-1-CARBOXYLATE
25,26,27,28-tetrahydroxycalix[4]arene monoethyl ether
Eprazinone 2HCl
D019141 - Respiratory System Agents > D005100 - Expectorants Eprazinone dihydrochloride is a gent with mucolytic, secretolytic, antitussive, and bronchial antispasmodic properties. Eprazinone dihydrochloride is a neurokinin 1 receptor (NK1R) ligand. Eprazinone dihydrochloride has the potential for chronic bronchitis treatment that improved pulmonary function and arterial partial pressure of oxygen[1][2].
(3R,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid
(2R,4R)-4-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLICACID
Belumosudil
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Boc-(2S,4S)-4-amino-1-Fmoc-pyrrolidine-2-carboxylic acid
1,1-Bis((R)-(dimethylamino)(phenyl)methyl)ferrocene
(6A,11B,16A,17A)-6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIENE-17-CARBOXYLIC ACID
3,3-[Oxybis(2,1-ethanediyloxy)]bis-1-propanamine (2Z)-2-butenedioate (1:2)
C10H24N2O3.2(C4H4O4) (452.2006)
2-tert-butylcyclopenta-1,3-diene,carbanide,hafnium(4+)
1-{2-[(4-Chlorophenyl)amino]-2-oxoethyl}-N-(1-isopropylpiperidin-4-YL)-1H-indole-2-carboxamide
({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-YL)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester
N-((1S)-1-(3-Chloro-1-naphthalenyl)ethyl)-2-(4-(4-fluorophenyl)-1-methyl-4-P iperidinyl)-N-methylacetamide
phosphono [(2E,7S,10E)-3,7,11,15-tetramethylhexadeca-2,10,14-trienyl] hydrogen phosphate
3-[[(1-tert-butyl-5-tetrazolyl)methyl-(thiophen-2-ylmethyl)amino]methyl]-6-ethoxy-1H-quinolin-2-one
N-[(2S,3R,6R)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6R)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(2-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoate
(1S,2S,4R,8R,9S,11R,12S,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
20-oxoleukotriene E4(1-)
A leukotriene anion that is the conjugate base of leukotriene E4 obtained by deprotonation of the two carboxy groups and protonation of the cysteinyl alpha-amino group; major species at pH 7.3.